Novel Complexes(소설 단지)란 무엇입니까?
Novel Complexes 소설 단지 - The performed electrochemical investigation testified the ability of novel complexes to undergo reversible oxidation to Ru(III) species. [1] A number of novel complexes of the formula [99gTc][Tc(N)(O2)2(L)] with bidentate ligands (L) (where L = deprotonated alanine, glycine, proline) were prepared by reacting a solution of nitrido-technetic(VI) acid with L in the presence of a source of H2O2. [2] Novel complexes of Zn(II), Cd(II), Ni(II), and Co(II) with 3,5-di-tert-butyl-1,2-benzoquinone 3-hyd-roxynaphthoyl hydrazone have been synthesized. [3] Novel complexes based on precious metals are being developed as viable alternatives, with the aim of overcoming resistance and minimising unwanted side effects. [4] Overall, results showed promising characteristics of the novel complexes using dendrimer-G2 both in vitro and in vivo. [5] Novel complexes of Ru (III), Cu (II) and Au (III) (2–4) were prepared using 6-phenyl-2-thioxo-4-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile (HL, 1) adopting either electrochemical or traditional chemical methods. [6] A facile reflux approach was employed in the design of novel complexes using ruthenium(II) and quercetin for enhanced anticancer applications. [7] The characterization of the novel complexes was performed with FT-IR, 1H NMR, 13C NMR, UV–Vis and mass spectroscopy. [8] The biological activity of the novel complexes was examined by screening eight different bacterial strains and two cancer cell lines. [9] Treatment of [RuCl2(CO)2]n with different phosphine ligands, four Ru(II) complexes of cis-, cis-, trans- RuCl2(CO)2L2 (L = PH(C6H11)2 (1), PPh3 (2), PPh2(C6F5) (3) and PMe3 (4)), in which 1 and 3 are novel complexes, have been generated in methylene chloride and isolated as pure compound in solid. [10] The novel complexes, Ga-DOTA-Dn-TATE (n = 0, 2, 5, 8, or 11), were designed, synthesized, and evaluated. [11] All these novel complexes in both states were systematically characterized with the help of different characterization tools like XRD, SEM-EDS, thermal analysis, XPS, IR, electronic spectroscopic and theoretical studies. [12] The one-electron reduction waves assignable to the TcIII6/TcIITcIII5 [Tc6(24e/25e)] process were observed for the novel complexes. [13] A variety of possible polymorphs in the Li Si S-(BH4) composition space have been identified using first principles and thermodynamic modeling that supports the likelihood of formation of such novel complexes. [14] The novel complexes were characterized by using 13C NMR, 1H NMR, elemental analysis, and FTIR spectroscopy techniques. [15] Further, it is possible for the novel complexes to be applied in chemical detecting, paramagnetic-luminescent and bio-imaging fields. [16]수행된 전기화학 조사는 Ru(III) 종으로 가역적 산화를 겪는 새로운 복합체의 능력을 입증했습니다. [1] 화학식 [99gTc][Tc(N)(O2)2(L)]과 두자리 리간드(L)(여기서 L = 탈양성자화 알라닌, 글리신, 프롤린)의 다수의 신규 복합체는 니트리도- technetic(VI) 산과 H2O2 공급원의 존재하에 L. [2] Zn(II), Cd(II), Ni(II) 및 Co(II)와 3,5-di-tert-butyl-1,2-benzoquinone 3-hyd-roxynaphthoyl hydrazone의 새로운 착물이 합성되었습니다. [3] 저항을 극복하고 원치 않는 부작용을 최소화하기 위한 목적으로 귀금속을 기반으로 한 새로운 복합체가 실행 가능한 대안으로 개발되고 있습니다. [4] 전반적으로, 결과는 시험관내 및 생체내 모두에서 덴드리머-G2를 사용한 신규 복합체의 유망한 특성을 보여주었다. [5] Ru(III), Cu(II) 및 Au(III)(2-4)의 새로운 착물은 6-페닐-2-티옥소-4-(트리플루오로메틸)-1,2-디하이드로피리딘-3-카보니트릴(HL , 1) 전기화학적 또는 전통적인 화학적 방법을 채택합니다. [6] 강화된 항암 적용을 위해 루테늄(II)과 케르세틴을 사용하는 새로운 복합체의 설계에 손쉬운 역류 접근법이 사용되었습니다. [7] 새로운 복합체의 특성화는 FT-IR, 1H NMR, 13C NMR, UV-Vis 및 질량 분광법으로 수행되었습니다. [8] 8개의 다른 박테리아 균주와 2개의 암세포주를 스크리닝하여 새로운 복합체의 생물학적 활성을 조사했습니다. [9] [RuCl2(CO)2]n을 다른 포스핀 리간드로 처리, cis-, cis-, trans- RuCl2(CO)2L2(L=PH(C6H11)2(1), PPh3(2)의 Ru(II) 착물 4개 ), PPh2(C6F5)(3) 및 PMe3(4))에서 1과 3은 신규 착물인 메틸렌 클로라이드에서 생성되어 고체에서 순수한 화합물로 분리되었습니다. [10] 새로운 복합체인 Ga-DOTA-Dn-TATE(n = 0, 2, 5, 8 또는 11)가 설계, 합성 및 평가되었습니다. [11] 두 상태의 이러한 모든 새로운 복합체는 XRD, SEM-EDS, 열 분석, XPS, IR, 전자 분광학 및 이론 연구와 같은 다양한 특성화 도구의 도움으로 체계적으로 특성화되었습니다. [12] TcIII6/TcIITcIII5[Tc6(24e/25e)] 과정에 할당할 수 있는 1전자 환원파가 새로운 복합체에 대해 관찰되었습니다. [13] Li Si S-(BH4) 조성 공간에서 다양한 가능한 다형체가 이러한 신규 복합체의 형성 가능성을 지원하는 열역학적 모델링 및 제1 원리를 사용하여 확인되었습니다. [14] 새로운 복합체는 13C NMR, 1H NMR, 원소 분석 및 FTIR 분광기 기술을 사용하여 특성화되었습니다. [15] 또한, 새로운 복합체는 화학적 검출, 상자성-발광 및 바이오 이미징 분야에 적용될 수 있습니다. [16]
18 naphthyridine 2 18 나프티리딘 2
A new series of novel complexes of type cis-[Ru(CO)2Cl2(L)2], L = 2-phenyl-1,8-naphthyridine, 2-(4′-nitrophenyl)-1,8-naphthyridine, 2-(4′-bromophenyl)-1,8-naphthyridine, 2-(4′-methylphenyl)-1,8-naphthyridine, 2-(3′-methoxyphenyl)-1,8-naphthyridine, 2-(2′-methoxyphenyl)-1,8-naphthyridine and 2-(4′-methoxyphenyl)-1,8-naphthyridine have been successfully synthesized and characterized. [1]유형 cis-[Ru(CO)2Cl2(L)2], L=2-페닐-1,8-나프티리딘, 2-(4'-니트로페닐)-1,8-나프티리딘, 2의 새로운 일련의 새로운 착물 -(4'-브로모페닐)-1,8-나프티리딘, 2-(4'-메틸페닐)-1,8-나프티리딘, 2-(3'-메톡시페닐)-1,8-나프티리딘, 2-(2'- 메톡시페닐)-1,8-나프티리딘 및 2-(4'-메톡시페닐)-1,8-나프티리딘이 성공적으로 합성되고 특성화되었습니다. [1]
Two Novel Complexes 두 개의 새로운 단지
Two novel complexes of Zn(II) and Cd(II) with Hmef (mefenamic acid) and bapen (N,N′-bis(3-aminopropyl)ethylenediamine) ligand were synthesized and characterized by infrared spectroscopy, elemental, thermal and single-crystal X-ray structure analysis. [1] Two novel complexes Zn2(chda)2(TPA)Cl2(1) and [Zn(chda)2(H2O)2](TPA)(H2O)2(2)[chda is a chiral ligand of trans-(1R,2R)-cyclohexanediamine, H2TPA is terephthalic acid] were synthesized at room temperature. [2] A new oxindolimine ligand derived from isatin (1H-indole-2,3-dione) and 2-aminomethylbenzimidazole was synthesized, leading to two novel complexes after metalation with copper(II) perchlorate or zinc(II) chloride, [Cu(isambz)2](ClO4)2 (complex 1) and [Zn(isambz)Cl2] (complex 2). [3] I also contributed to the discovery of two novel complexes both containing the RNA helicase Mtr4, which is a master player of the nuclear surveillance system. [4] Two novel complexes Zn2(chda)2(TPA)Cl2(1) and [Zn(chda)2(H2O)2](TPA)(H2O)2(2)[chda is a chiral ligand of trans-(1R,2R)-cyclohexanediamine, H2TPA is terephthalic acid] were synthesized at room temperature. [5] Two novel complexes [Co5(tBu-sao)6(MeO)2Py5] (1) and [Fe(bpy)3]·[Fe6O2(SO4)2(L)4(MeO)4(MeOH)2] (2) have been synthesized through one-pot reactions using tBu-saoH2. [6]Zn(II) 및 Cd(II)와 Hmef(mefenamic acid) 및 bapen(N,N'-bis(3-aminopropyl)ethylenediamine) 리간드의 두 가지 새로운 착물을 합성하고 적외선 분광법, 원소, 열 및 단일- 결정 X선 구조 분석. [1] 2개의 새로운 복합체 Zn2(chda)2(TPA)Cl2(1) 및 [Zn(chda)2(H2O)2](TPA)(H2O)2(2)[chda는 트랜스-(1R,2R의 키랄 리간드) )-시클로헥산디아민, H2TPA는 테레프탈산] 실온에서 합성하였다. [2] nan [3] nan [4] 2개의 새로운 복합체 Zn2(chda)2(TPA)Cl2(1) 및 [Zn(chda)2(H2O)2](TPA)(H2O)2(2)[chda는 트랜스-(1R,2R의 키랄 리간드) )-시클로헥산디아민, H2TPA는 테레프탈산] 실온에서 합성하였다. [5] nan [6]
Three Novel Complexes 3개의 새로운 단지
Here, based on Ag(I) and bztpy, three novel complexes, namely [Ag2(bza)2(μ4-bztpy)] (1), [Ag2(μ-ipa)(μ4-bztpy)]·EtOH·3H2O (2) and [Ag3(pda)(μ-pda)1/2(μ4-bztpy)2]·3EtOH·6H2O (3) (Hbza = benzoic acid, H2ipa = isophthalic acid and H2pda = 2,4-pyridinedicarboxylic acid), have been synthesized with the assistance of auxiliary carboxylates. [1] The synthetic feasability of the concept is demonstrated with the preparation of three novel complexes. [2] Three novel complexes were identified: Al(BH4)3·CH3NH2BH3 having a molecular structure similar to that of Al(BH4)3·AB but different dehydrogenation properties, as well as [Al(CH3NH2BH3)2Cl2][AlCl4] and [Al(NH2CH2CH2NH2)(BH4)2][Al(BH4)4], rare examples of Al3+ making part of the cations and anions simultaneously. [3]여기서, Ag(I) 및 bztpy를 기반으로 하는 세 가지 신규 착물, 즉 [Ag2(bza)2(μ4-bztpy)](1), [Ag2(μ-ipa)(μ4-bztpy)]·EtOH·3H2O( 2) 및 [Ag3(pda)(μ-pda)1/2(μ4-bztpy)2]·3EtOH·6H2O (3) (Hbza = 벤조산, H2ipa = 이소프탈산 및 H2pda = 2,4-피리딘디카르복실산) , 보조 카르복실레이트의 도움으로 합성되었습니다. [1] 개념의 합성 가능성은 세 가지 새로운 복합체의 준비로 입증되었습니다. [2] nan [3]
These Novel Complexes 이 새로운 단지
These novel complexes were characterized using various techniques and assayed for antimicrobial and antitumor activity. [1] These novel complexes may have facilitated diversification across environments where the spectrum of light available for photosynthesis varies widely. [2] These novel complexes, containing the positron emitting isotope 18F, may have potential applications in positron emission tomography (PET). [3]이 새로운 복합체는 다양한 기술을 사용하여 특성화되었으며 항균 및 항종양 활성에 대해 분석되었습니다. [1] 이러한 새로운 복합체는 광합성에 사용할 수 있는 빛의 스펙트럼이 광범위하게 변하는 환경 전반에 걸쳐 다양화를 촉진했을 수 있습니다. [2] nan [3]
All Novel Complexes 모든 신규 단지
All novel complexes have been characterized by spectroscopic and electrochemical techniques. [1] All novel complexes 1-4 were fully characterized, including the solid state structures of 1 and 2 determined by single crystal X-ray diffraction. [2] All novel complexes are fully characterized including NMR, IR and UV-Vis spectroscopy, MS spectrometry, X-ray crystallography, elemental analysis as well as cyclic voltammetry. [3]모든 새로운 복합체는 분광 및 전기화학적 기술에 의해 특징지어졌습니다. [1] 모든 신규 착물 1-4는 단결정 X선 회절에 의해 결정된 1 및 2의 고체 상태 구조를 포함하여 완전히 특성화되었습니다. [2] nan [3]
Fmy Novel Complexes Fmy 소설 컴플렉스
Based on H4TPTC and 1,2-bimb/1,3-bimb ligands, four novel complexes, namely, {[Cu(TPTC)(1,2-bimb)2]·4. [1] In this study, we synthesized four novel complexes of Co (III) by the reaction of the metal ions with the salen ligands. [2]H4TPTC 및 1,2-bimb/1,3-bimb 리간드를 기반으로 하는 4개의 신규 복합체, 즉 {[Cu(TPTC)(1,2-bimb)2]·4. [1] 이 연구에서 우리는 금속 이온과 살렌 리간드의 반응에 의해 Co(III)의 4가지 새로운 착물을 합성했습니다. [2]
Desired Novel Complexes 원하는 신규 단지
1-Methylpyridin-1-iumterpyridine ligands and their metallo-complexes were first designed and synthesized, and the association of methylpyridiniums with dibenzo-24-crown-8 ether(DB24C8) afforded the desired novel complexes through host-guest interactions. [1] 1-Methylpyridin-1-iumterpyridine ligands and their metallo-complexes were first designed and synthesized, and the association of methylpyridiniums with dibenzo-24-crown-8 ether(DB24C8) afforded the desired novel complexes through host-guest interactions. [2]1-Methylpyridin-1-iumterpyridine 리간드와 금속 착물이 먼저 설계 및 합성되었으며, methylpyridinium과 dibenzo-24-crown-8 ether(DB24C8)의 결합은 호스트-게스트 상호 작용을 통해 원하는 새로운 착물을 제공했습니다. [1] 1-Methylpyridin-1-iumterpyridine 리간드와 금속 착물이 먼저 설계 및 합성되었으며, methylpyridinium과 dibenzo-24-crown-8 ether(DB24C8)의 결합은 호스트-게스트 상호 작용을 통해 원하는 새로운 착물을 제공했습니다. [2]
Six Novel Complexes 6개의 소설 단지
Six novel complexes, [Ni(C36H34N2O10)]·2. [1] Six novel complexes of transition metal namely, [CoLCl2(H2O)2]0. [2]6개의 새로운 착물, [Ni(C36H34N2O10)]·2. [1] 6개의 새로운 전이금속 착물, 즉 [CoLCl2(H2O)2]0. [2]
Several Novel Complexes 여러 소설 단지
Several novel complexes are involved in vernalization and pathogen defense, traits critical to agriculture. [1] With the aim of better understanding the mechanisms governing the spontaneous cis–trans isomerization of the olefins promoted by palladium(0) centers, we have synthesized several novel complexes bearing (Z)- or (E)-1,2-ditosylethene and a combination of other two spectator ligands including phosphines (PPh3 and 1,3,5-triaza-7-phosphaadamantane), isocyanides (i. [2]몇 가지 새로운 복합체가 농업에 중요한 특성인 vernalization 및 병원체 방어에 관여합니다. [1] 팔라듐(0) 중심에 의해 촉진되는 올레핀의 자발적인 시스-트랜스 이성질체화를 지배하는 메커니즘을 더 잘 이해하기 위해, 우리는 (Z)- 또는 (E)-1,2-디토실에텐과 그 조합을 포함하는 몇 가지 새로운 착물을 합성했습니다. 포스핀(PPh3 및 1,3,5-트리아자-7-포스파아다만탄), 이소시아나이드(i. [2]
novel complexes zn2 신규 복합체 Zn2
Two novel complexes Zn2(chda)2(TPA)Cl2(1) and [Zn(chda)2(H2O)2](TPA)(H2O)2(2)[chda is a chiral ligand of trans-(1R,2R)-cyclohexanediamine, H2TPA is terephthalic acid] were synthesized at room temperature. [1] Two novel complexes Zn2(chda)2(TPA)Cl2(1) and [Zn(chda)2(H2O)2](TPA)(H2O)2(2)[chda is a chiral ligand of trans-(1R,2R)-cyclohexanediamine, H2TPA is terephthalic acid] were synthesized at room temperature. [2]2개의 새로운 복합체 Zn2(chda)2(TPA)Cl2(1) 및 [Zn(chda)2(H2O)2](TPA)(H2O)2(2)[chda는 트랜스-(1R,2R의 키랄 리간드) )-시클로헥산디아민, H2TPA는 테레프탈산] 실온에서 합성하였다. [1] 2개의 새로운 복합체 Zn2(chda)2(TPA)Cl2(1) 및 [Zn(chda)2(H2O)2](TPA)(H2O)2(2)[chda는 트랜스-(1R,2R의 키랄 리간드) )-시클로헥산디아민, H2TPA는 테레프탈산] 실온에서 합성하였다. [2]